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Background: Increasing evidence suggests a role for inflammation in the development of type 
2 diabetes. Elevated levels of inflammatory cytokines, including interleukin-6, have been associ-
ated with insulin resistance, and dietary lipids can increase cytokine production. The objective 
of this study was to determine whether a single nucleotide polymorphism near the IL6 gene 
(rs7801406) modifies the relationship between dietary fat and markers of insulin sensitivity.
Methods: Subjects were healthy men and women aged 20–29 years from the Toronto 
  Nutrigenomics and Health Study. Dietary intake was estimated using a one-month semiquan-
titative food frequency questionnaire. Fasting blood samples were taken for genotyping and 
biomarker measurement.
Results: The single nucleotide polymorphism was not associated with any of the measures 
of insulin sensitivity. However, it modified the relationship between total dietary fat and 
the homeostasis model assessment of insulin resistance (P = 0.053 for interaction). Total 
fat intake was positively related to HOMA-IR in individuals homozygous for the G allele 
(β = 0.005 ± 0.002, P = 0.03), but not among heterozygotes. There was an inverse relationship 
between total fat intake and HOMA-IR in individuals who were homozygous for the A allele 
(β = −0.012 ± 0.006, P = 0.047).
Conclusion: These findings suggest that dietary fat influences insulin sensitivity differently 
depending on genotype.
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Introduction
Type 2 diabetes mellitus (T2DM) is a growing global health problem, representing 
one of the leading preventable causes of mortality worldwide.1 T2DM is preceded by 
insulin resistance, whereby the biological effects of insulin are less than expected for 
glucose disposal and suppression of endogenous glucose production.2 This decrease 
in insulin action is compensated for by an increase in insulin secretion3 and, over 
time, insulin resistance leads to beta-cell dysfunction and eventual destruction.3 
Several factors contribute to the progression of T2DM, including both genetics and 
the environment.
One such environmental factor that contributes to insulin resistance is high avail-
ability of fatty acids.4 With prolonged exposure to excess dietary fat, the storage 
capacity of adipose tissue is exceeded and fatty acids are released into the circulation 
to be stored in nonadipose tissues, including skeletal muscle.5,6 Within the muscle, 
fatty acid metabolites can contribute to insulin resistance directly and also activate 
inflammatory signalling.4
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It has been proposed that T2DM is an acute-phase 
disease in which increased   concentrations of cytokines are 
secreted under the influence of stimuli such as overnutrition 
in predisposed individuals.7 The acute-phase response is an 
inflammatory outcome with a specific cytokine profile that is 
activated in response to exogenous threats, such as   pathogens 
or dietary factors, in particular fatty acid   consumption. The 
cytokines released are primarily derived from activated 
macrophages and can directly enhance insulin resistance in 
adipocytes, and muscle and liver cells.8,9 Interleukin-6 is a 
proinflammatory cytokine that is increased in T2DM, indepen-
dent of obesity.   Chronically elevated levels of   interleukin-6 
have been related to a number of metabolic abnormalities 
associated with insulin resistance.10–13   Prolonged exposure 
to interleukin-6 may cause insulin resistance in muscles14 
and increases the subsequent risk of developing T2DM.10–13 
Levels of interleukin-6 and other inflammatory markers can 
be modified by diet, specifically dietary fat, and contribute 
to the risk and manifestation of T2DM.
Consumption of a high saturated fat diet is associated 
with higher concentrations of proinflammatory markers,15,16 
and has also been shown to increase the expression of 
proinflammatory genes.17 Conversely, in a cross-sectional 
study, increased n-3 polyunsaturated fatty acid consump-
tion was associated with decreased plasma concentrations 
of interleukin-6.18 However, these results are not consistent, 
suggesting that other factors may play a role in the relation-
ship between fat consumption and cytokine synthesis.
Genetic polymorphisms in IL6 can affect circulating levels 
of interleukin-619 and have been associated with a modified 
risk of T2DM.20 We recently showed that the rs7801406 
single nucleotide polymorphism near the IL6 gene is inversely 
related to insulin levels in a population of monozygotic and 
dizygotic twins.21 This single nucleotide polymorphism is in 
linkage disequilibrium with two common intronic polymor-
phisms in IL6, the rs1474347 (linkage disequilibrium = 0.85) 
and rs1474348 (linkage disequilibrium = 0.84), that exhibit 
linkage disequilibrium = 1.21 While lifestyle and genetics each 
play a role in the development of T2DM, study results have 
been inconsistent and interactions between these two types 
of risk factors may help explain some of the interindividual 
variation. The objective of the present study was to determine 
whether the rs7801406 single nucleotide polymorphism that 
was recently shown to modify the serum levels of insulin21 
is associated with markers of T2DM and influences the asso-
ciation between dietary fat intake and insulin sensitivity in a 
population of young adults.
Methods
Study population
The Toronto Nutrigenomics and Health study is an investiga-
tion of the role of genetics and nutrition in health and bio-
markers of chronic disease. This population consists of men 
and women aged 20–29 years recruited from the   University 
of Toronto, Canada.22,23 In this population, 47% of subjects 
are Caucasian, 35% are East Asian, 11% are South Asian, 
and 7% are considered “other” (eg, mixed   ethnicities or 
smaller sizes of ethnocultural groups).   Individuals who 
may have under-reported (#800 kcal/day) or over-reported 
($3500 kcal/day female, $4000 kcal/day male, n = 94) 
their energy intakes, those with diabetes or other condi-
tions characterized by increased inflammation (n = 57; 
Crohn’s disease, ulcerative colitis, arthritis) and individuals 
with possible acute inflammation (n = 9), as determined 
by C-reactive protein $ 10 mg/L, were excluded from the 
analyses.   Individuals who were missing relevant dietary 
and biomarker data were also excluded (n = 28). The final 
population consisted of 707 individuals. Written informed 
consent was obtained from all participants, and the study was 
approved by the Ethics Review Committee at the University 
of Toronto.
Dietary assessment
A 196-item Toronto-modified Willett food-frequency ques-
tionnaire was used to assess habitual dietary intake over the 
past month. Each subject was instructed on how to complete 
the food-frequency questionnaire using visual aids for por-
tion sizes in order to improve the accuracy of self-reported 
food intake.
Anthropometrics and energy expenditure
Anthropometric measurements, including height, weight, and 
waist circumference, were measured and body mass index 
(kg/m2) was calculated. Modifiable activity was measured by 
questionnaire and metabolic equivalent hours per day was 
calculated. This measurement represents both leisure and 
occupational activity, not including sedentary hours of sleep-
ing or sitting. One metabolic equivalent is equal to 1 kcal 
expended per kg body weight per hour sitting at rest.24
Laboratory measurements
Each subject had venous blood drawn after a 12-hour 
overnight fast to measure biomarkers of glucose and lipid 
metabolism as well as highly sensitive C-reactive protein 
using standard clinical procedures. Insulin and glucose 
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measurements were used to calculate insulin sensitivity 
as   homeostasis model assessment of insulin resistance 
(HOMA-IR), using the following equation:
  HOMAI R
Insulin
pmol
L
G
mmol
L
−=

 

 
×

 

  []
.
[]
. 71 82 25
lu e cos
Genotyping and allele frequency
The rs7801406 polymorphism was genotyped in the study 
subjects based upon its high frequency in the general popu-
lation, its association with lower serum insulin levels as 
previously reported,21 and its strong linkage disequilibrium 
(.80%) with two common polymorphisms in the IL6 
gene (rs1474347 and rs1474348). DNA was isolated from 
whole blood using the GenomicPrep Blood DNA isolation 
kit (Amersham Pharmacia Biotech, Piscataway, NJ). The 
rs7801406 polymorphism was detected using TaqMan® 
allelic discrimination assays (ABI C-29151539-10) from 
Applied Biosystems (Foster City, CA), with real-time poly-
merase chain reaction on an ABI 7000 sequence detection 
system. Polymerase chain reaction conditions were 95°C for 
10 minutes and 40 cycles of 95°C for 15 seconds and 60°C 
for one minute.
When genotyped, 41% of Caucasians were G/G 
  homozygotes for rs7801406, 45% were G/A heterozygotes, 
and 14% were A/A homozygotes. Of the South Asian 
  subjects, 64% were G/G, 32% were G/A, and 4%, were A/A. 
Among the East Asian subjects, 98.9% were G/G, 0.9% were 
G/A, and 0.2% were A/A. Because of the low frequency 
of this polymorphism among East Asians, they were not 
included in any of the analyses.
Statistical analysis
All statistical analyses were performed using SAS version 9.1 
(SAS Institute Inc, Cary, NC). The GLM procedure in SAS 
was used to perform a one-way analysis of variance to test 
for differences in the characteristics between genotypes. The 
CONTRAST statement was used for pairwise group compari-
sons and the χ2 test was used to analyze categorical variables. 
Non-normally distributed variables were loge-transformed 
for analysis and their antilogs are reported. High-sensitivity 
C-reactive protein was transformed following a gamma dis-
tribution using the GENMOD procedure, and the median and 
interquartile range values for this variable are given.
The GLM procedure was also used to test whether the 
association of dietary total, saturated fat, monounsaturated, 
or polyunsaturated fatty acids, as continuous or categorical 
variables, with insulin sensitivity varied across the three 
genotypes for each polymorphism. A diet-gene interaction 
was found for total dietary fat and the rs7801406 polymor-
phism on HOMA-IR. Covariates that were associated with 
the outcome and reduced the variance of the relationship 
between total dietary fat and HOMA-IR were included in 
the model. Potential covariates that were associated with 
HOMA-IR or differed between genotypes were added 
individually to the model to test whether the interaction 
changed. These variables were not included in the final 
model. No differences or interactions were found between 
the genotypes and any of these potential confounders. Total 
dietary fat intake was adjusted for total energy intake using 
the nutrient density method (percent of energy from dietary 
fatty acids).25 The slopes of the three lines were estimated 
using the GLM procedure on a fully adjusted model includ-
ing the genotype and genotype × total fat interaction term. 
Departure of genotype distributions from Hardy-Weinberg 
equilibrium was assessed using a χ2 test with one degree of 
freedom. Significant P values are two-sided and #0.05.
Results and discussion
The minor allele frequency in the final study population 
was 20.8% and the single nucleotide polymorphism was in 
Hardy-Weinberg equilibrium (P = 0.94). Individuals who 
were homozygous for the G allele were younger than the 
heterozygotes; however, this absolute difference was only 
0.5 years. Those who were homozygous for the A allele 
consumed more calories than those who were heterozygotes. 
Therefore, age and calorie consumption, as well as ethnicity, 
were all controlled for when analyzing the association of the 
examined single nucleotide polymorphism with metabolic 
characteristics. There were no significant differences between 
the genotypes for any of the measured metabolic characteris-
tics, including HOMA indices, insulin and glucose, or family 
history of diabetes (see Table 1).
We evaluated whether the rs7801406 polymorphism 
modifies the association between dietary fat and   biomarkers 
of insulin sensitivity (HOMA-IR and serum insulin   levels). 
A significant interaction was found between the genotypes and 
total dietary fat on serum insulin (P = 0.02, adjusted for waist 
circumference, triglycerides, ethnicity, and serum glucose) 
and HOMA-IR (P = 0.053, adjusted for waist circumfer-
ence, ethnicity, triglycerides, and total cholesterol:HDL-
cholesterol). Dietary fat intake was inversely related to 
HOMA-IR in individuals homozygous for the A allele 
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Table 1 Clinical and metabolic characteristics and dietary intake by rs7801406 genotype*
rs7801406
G/G (n = 333) G/A (n = 305) A/A (n = 69) P**
Age (years) 22.6 ± 0.1a 23.1 ± 0.1b 23.1 ± 0.3a,b 0.02
Gender (% female) 61.3% 72.5% 71.0% 0.008
BMI (kg/m2) 23.1 ± 0.2 23.0 ± 0.2 23.4 ± 0.4 0.67
Smoking status (%)
Never 82.6% 79.7% 85.5%
Past 9.3% 13.4% 2.9%
Present 8.1% 6.9% 11.6% 0.07
Physical activity (MET ⋅ hour/week) 8.2 ± 0.2 7.8 ± 0.2 8.6 ± 0.4 0.06
Waist circumference (cm) 76.6 ± 0.5 76.6 ± 0.6 77.7 ± 1.1 0.58
Systolic blood pressure (mmHg) 116.8 ± 0.6 117.3 ± 0.7 118.4 ± 1.2 0.39
Diastolic blood pressure (mmHg) 69.9 ± 0.5 70.2 ± 0.6 69.3 ± 1.1 0.69
Total cholesterol (mmol/L) 4.1 ± 0.05 4.3 ± 0.06 4.2 ± 0.10 0.17
LDL cholesterol (mmol/L) 2.3 ± 0.04 2.3 ± 0.05 2.3 ± 0.09 0.67
HDL cholesterol (mmol/L) 1.5 ± 0.02 1.5 ± 0.03 1.4 ± 0.05 0.40
Triglycerides (mmol/L) 0.94 ± 0.03 1.0 ± 0.03 1.0 ± 0.06 0.19
Free fatty acids (μmol/L) 453 ± 14.9 484 ± 17.3 513 ± 32.4 0.11
hs-CRP (mg/L) 0.5 ± 0.9 0.5 ± 1.0 0.6 ± 1.6 0.49
Glucose (mmol/L) 4.8 ± 0.02 4.8 ± 0.02 4.8 ± 0.05 0.47
Insulin (pmol/L) 52.7 ± 1.7 52.8 ± 2.0 53.0 ± 3.8 0.93
hOMA-IR 1.6 ± 0.05 1.6 ± 0.06 1.6 ± 0.1 0.94
HOMA-β 116.8 ± 4.5 116.0 ± 5.2 113.3 ± 9.8 0.74
Family history of diabetes (%) 14.1% 11.5% 7.3% 0.24
Energy intake (kcal/day) 1989 ± 35.1a,b 1967 ± 36.7a 2187 ± 77.2b 0.03
Total fat (% energy) 30.0 ± 0.4 30.0 ± 0.4 31.0 ± 0.8 0.52
SFA (% energy) 9.6 ± 0.1 9.9 ± 0.1 10.1 ± 0.3 0.19
MUFA (% energy) 12.0 ± 0.2 11.9 ± 0.2 12.5 ± 0.5 0.36
PUFA (% energy) 5.7 ± 0.1 5.6 ± 0.1 5.5 ± 0.2 0.46
Cholesterol (mg/d) 242.4 ± 7.3 235.1 ± 7.6 252.3 ± 15.9 0.58
Carbohydrates (% energy) 52.9 ± 0.5 53.0 ± 0.5 51.9 ± 1.0 0.60
Fiber (g/100 g carbohydrates) 9.2 ± 0.2 9.4 ± 0.2 9.3 ± 0.4 0.60
Protein (% energy) 16.9 ± 0.2 16.9 ± 0.2 16.9 ± 0.4 0.98
Alcohol (g/day) 6.9 ± 0.5 7.1 ± 0.6 7.9 ± 1.2 0.57
Notes: *Metabolic characteristics are adjusted for subject characteristics and dietary variables that were different between each genotype (ethnicity, age, gender, energy 
intake). Metabolic characteristics include: waist circumference, systolic and diastolic blood pressures, total, LDL and hDL cholesterol, triglycerides, free fatty acids, hs-CRP, 
glucose, insulin, hOMA-IR and hOMA-β. **P values for differences between genotypes were obtained using one-way analysis of variance, and the Chi-square test was used to 
test for differences between genotypes in categorical variables. Median ± interquartile range given for hs-CRP. a,bDifferent letters represent statistically significant differences 
between groups (P < 0.05). 
Abbreviations: hs-CRP, high-sensitivity C-reactive protein; hOMA-IR, homeostasis model assessment of insulin resistance; hOMA-β, homeostasis model assessment of beta 
cell function; LDL, low-density lipoprotein; hDL, high-density lipoprotein; sFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
(β = −0.012 ± 0.006, P = 0.047); however, a positive relation-
ship was found among G/G homozygotes (β = 0.005 ± 0.002, 
P = 0.03, Figure 1). The association between dietary fat and 
HOMA-IR in the G/G homozygotes was significantly dif-
ferent from the A/A homozygotes (P = 0.02), but not the 
heterozygotes (P = 0.78). However, the relationship in A/A 
homozygotes differed significantly from that in the heterozy-
gotes (P = 0.03).   Furthermore, the relationship between 
dietary total fat intake and HOMA-IR was not significant 
among heterozygotes (β = 0.005 ± 0.093, P = 0.51) and the 
slope of this relationship did not differ significantly from the 
other genotype groups. No interactions were observed with 
any of the other   covariates in the model.
As illustrated in Figure 1, the interaction between 
rs7801406 genotype and dietary fat intake on HOMA-IR 
continued to be significant when total fat intake was 
  categorized according to recommended intake levels (#30% 
of energy, P = 0.05). Comparing those who consumed total 
fat above the recommendation cutoff with individuals who 
met the recommendations in each genotype, mean HOMA-IR 
levels were significantly higher in subjects with the G/G 
genotype who consumed diets high in total fat (P = 0.03). 
No differences were observed between intake groups in 
the other genotypes (G/A, P = 0.89; A/A, P = 0.15). The 
inverse relationship observed in the A/A homozygotes 
was not significant, probably due to small sample size in 
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this subgroup after stratification. We investigated whether 
ethnicity affected the associations between IL6 genotype and 
dietary fat; however, there was no interaction between the 
three factors. Moreover, stratification by ethnicity within the 
genotypes produced a sample size in the A/A group which 
did not permit a statistically meaningful conclusion.
The objective of this study was to determine whether the 
rs7801406 single nucleotide polymorphism is associated 
with factors related to predisposition to T2DM and if it can 
modify the relationship between dietary fat and disease risk 
factors. As mentioned above, our group recently found the 
rs7801406 polymorphism to be linked to lower serum insulin 
levels.21 This single nucleotide polymorphism is located near 
the IL6 gene and is in linkage disequilibrium with two com-
mon polymorphisms in IL6 (see above). A common single 
nucleotide polymorphism in the promoter region of IL6 
(rs1800795, −174 G . C), was previously reported, in a large 
meta-analysis study, to reduce the risk of developing T2DM 
by nearly 10%.20 Although these findings suggest a role for 
IL6 polymorphisms in T2DM, additional studies confirming 
these results and investigating other polymorphisms, both in 
the IL6 gene or in a strong linkage disequilibrium with com-
mon IL6 single nucleotide polymorphisms, are necessary. In 
addition, studies examining gene-environment interactions 
can also provide insight into the mechanisms by which IL6 
plays a role in the etiology of T2DM.
In the present study, rs7801406 was not associated with 
markers of T2DM; however, it modified the association 
between dietary fat and HOMA-IR. While this study does 
not confirm the association between rs7801406 and serum 
  insulin levels as previously reported,21 the   interaction between 
dietary fat and insulin could help explain this inconsistency. 
Overall, we found that rs7801406, although not associated 
with metabolic phenotypes related to T2DM risk, modified the 
relationship between dietary fat intake and insulin sensitivity 
in a population of young adults. Further studies are needed to 
confirm these results in other populations and to determine 
what effects this polymorphism has on interleukin-6 levels and 
function in the presence of a high-fat or low-fat diet.
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